ADAK 2022 ADAK vs Joseph Wasike Wesonga

In November 2022 the Anti-Doping Agency of Kenya (ADAK) reported an anti-doping rule violation against the bodybuilder Joseph Wasike Wesonga after his sample tested positive for the prohibited substances Trenbolone and Letrozole.

Following notification a provisional suspension was ordered whereas the Athlete submitted a brief statement in his defence. Thereupon he failed to cooperate with the proceedings, nor responded to the communications, nor attended the hearing of the Kenya Sports Disputes Tribunal.

In his brief statement the Athlete denied the intentional use of the substances and alleged that the supplements he had used were the source of the prohibited substances.

ADAK contended that the Athlete's acted intentionally and that he failed to demonstrate how the substances had entered his system. Moreover because his alleged supplements didn't contain prohibited substances.

The Panel finds that the presence of the prohibited substances had been established in the Athlete's sample and accordingly that he committed an anti-doping rule violation.

The Panel deemst that the Athlete's violation was intentional and that he provided no evidence on how the substances had entered his system, nor grounds for a reduced sanction.

Therefore the Panel decides on 29 June 2023 to impose a 4 year period of ineligibility on the Athlete, starting on the date of the decision.

Original document

Parameters

Legal Source
National Decisions
Date
29 June 2023
Arbitrator
Mola Owinyi, Allan
Ouko, Gabriel
Sifuna-Shiveka, Elynah
Original Source
Anti-Doping Agency of Kenya (ADAK)
Country
Kenya
Language
English
ADRV
Adverse Analytical Finding / presence
Legal Terms
Case law / jurisprudence
Intent
Period of ineligibility
Sport/IFs
Bodybuilding & Fitness (IFBB) - International Federation of Bodybuilding & Fitness
Other organisations
Anti-Doping Agency of Kenya (ADAK)
Laboratories
Doha, Qatar: Antidoping Lab Qatar, Doping Analysis Lab
Doping classes
S1. Anabolic Agents
S4. Hormone And Metabolic Modulators
Substances
Letrozole
Trenbolone (17β-hydroxyestr-4,9,11-trien-3-one)
Various
Lack of cooperation / obstruction
Supplements
Document type
Pdf file
Date generated
1 August 2023
Date of last modification
14 September 2023
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin